2+ tr'/> In Silico Populations Optimized on Optogenetic Recordings Predict Drug Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
首页> 外文会议>Computing in Cardiology Conference >In Silico Populations Optimized on Optogenetic Recordings Predict Drug Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
【24h】

In Silico Populations Optimized on Optogenetic Recordings Predict Drug Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

机译:在计算机上优化的光遗传学记录人口预测人类诱导的多能干细胞衍生心肌细胞的药物作用。

获取原文

摘要

All-optical high-throughput systems allow simultaneous high resolution action potential (AP) and Ca2+ transient (CaTr) measurements from cardiomyocytes within multicellular context, offering means to speed up in vitro drug tests. Here, we aim to develop experimentally-constrained in silico models of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and hiPSC-CM populations to predict drug effects in humans, by leveraging functional data obtained by all-optical means. Using multi-objective genetic algorithms (MoGAs), we constructed three control populations of in silico hiPSC-CMs, constrained with experimental data of APs and CaTrs recorded at room temperature and non-paced conditions from three different plates containing hiPSC-CM syncytia. We then simulated the effect of increasing doses of Diltiazem (130 models), Cisapride (200 models) and Astemizole (200 models) in the three populations, respectively. Comparing model predictions with the experimental drug administration (not used for the optimization/calibration of the populations) revealed good agreement with experiments: e.g. Diltiazem shortened APs while Astemizole and Cisapride prolonged APs.
机译:全光学高通量系统可同时实现高分辨率动作电位(AP)和Ca 2 + 在多细胞环境中从心肌细胞进行瞬时(CaTr)测量,为加速体外药物测试提供了手段。在这里,我们的目标是通过利用通过全光学手段获得的功能数据,开发实验诱导的人诱导多能干细胞源性心肌细胞(hiPSC-CMs)和hiPSC-CM群体计算机模型,以预测对人类的药物作用。我们使用多目标遗传算法(MoGA),构建了三个计算机控制的hiPSC-CM种群,并结合了室温和无节奏条件下从三个包含hiPSC-CM合胞体的平板上记录的AP和CaTr的实验数据进行了约束。然后,我们分别模拟了在这三个人群中增加地尔硫卓(130个模型),西沙必利(200个模型)和阿司咪唑(200个模型)剂量的影响。将模型预测值与实验性药物管理(未用于群体的优化/校准)进行比较,可以得出与实验的良好一致性:地尔硫卓缩短了AP,而阿斯咪唑和西沙必利则延长了AP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号